Please login to the form below

Not currently logged in
Email:
Password:

NHS boss resigns ahead of 'damning' report

The chief executive of Birmingham Children's Hospital has resigned with immediate effect ahead of the publication of a report by the Healthcare Commission

The chief executive of Birmingham Children's Hospital has resigned with immediate effect ahead of the publication of a report by the Healthcare Commission, which investigated the hospital after concerns were raised by its own doctors.

This week's Sunday Observer newspaper reported that the leading children's hospital is to be censured by the NHS watchdog. The Healthcare Commission will issue a highly critical report highlighting numerous failings in both quality of care and management processes.

Birmingham Children's Hospital NHS Foundation Trust chairwoman Joanna Davis confirmed that the chief Paul O'Connor has resigned and "has not been removed from his position".

The investigation, which was launched in November after the Observer obtained an internal NHS report which looked at the clinical standards at the children's hospital questioning consultants across different departments. The Observer stated the report, commissioned by the NHS Primary Care Trusts in Birmingham, found that support for surgeons undertaking kidney transplants at the hospital was poor and transplant services for children with serious liver failure were like "a third-class service [that is] putting patients at risk."

A Birmingham Children's Hospital spokeswoman said: "We can answer questions when the Healthcare Commission's report is out, but we cannot make any comments until that happens."

9th March 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics